AMPH logo

AMPH EBITDA

Annual EBITDA

$240.29 M
+$94.13 M+64.40%

December 31, 2023

Summary

Performance

1-Year Change

+64.4%

3-Year Change

+695.91%

5-Year Change

+3416.67%

15-Year Change

+1243.55%

AMPH EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.54%
AMPH annual EBITDA is higher than 89.54% of companies in Healthcare sector

High & Low

All-time High

$240.29 M
AMPH annual EBITDA is currently at an all-time high

3-Year Low

$111.56 M
AMPH annual EBITDA is currently +115.40% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
AMPH previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
AMPH next annual earnings announcement is scheduled for Feb 28, 2025

OtherAMPHprofitabilitymetrics:

Annual Revenue

$644.39 M
AMPH annual revenue is $644.39 million

Annual Net Income

$137.54 M
AMPH annual net profit is $137.54 million

Annual EBIT

$198.52 M
AMPH annual earnings before interest & taxes is $198.52 million

Annual EPS

$2.60
AMPH annual earnings per share is $2.60

Quarterly EBITDA

$68.81 M
-$4.18 M-5.73%

September 30, 2024

Summary

Performance

3-Month Change

-5.73%

1-Year Change

-24.31%

3-Year Change

+66.37%

5-Year Change

+901.81%

AMPH Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.56%
AMPH quarterly EBITDA is higher than 88.56% of companies in Healthcare sector

High & Low

All-time High

$90.91 M
AMPH quarterly EBITDA is currently -24.31% below its historical high of $90.91 million

3-Year Low

$30.38 M
AMPH quarterly EBITDA is currently +126.53% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AMPH previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
AMPH next earnings announcement is scheduled for Feb 28, 2025

OtherAMPHprofitabilitymetrics:

Quarterly Revenue

$191.21 M
AMPH quarterly revenue is $191.21 million

Quarterly Net Income

$40.43 M
AMPH quarterly net profit is $40.43 million

Quarterly EBIT

$54.38 M
AMPH quarterly earnings before interest & taxes is $54.38 million

Quarterly EPS

$0.78
AMPH quarterly earnings per share is $0.78

TTM EBITDA

$276.85 M
-$22.10 M-7.39%

September 30, 2024

Summary

Performance

3-Month Change

-7.39%

1-Year Change

+23.14%

3-Year Change

+82.93%

5-Year Change

+239.83%

AMPH TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.32%
AMPH TTM EBITDA is higher than 89.32% of companies in Healthcare sector

High & Low

All-time High

$298.95 M
AMPH TTM EBITDA is currently -7.39% below its historical high of $298.95 million

3-Year Low

$111.56 M
AMPH TTM EBITDA is currently +148.17% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AMPH previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
AMPH next earnings announcement is scheduled for Feb 28, 2025

OtherAMPHprofitabilitymetrics:

TTM Revenue

$723.55 M
AMPH TTM revenue is $723.55 million

TTM Net Income

$157.72 M
AMPH TTM net profit is $157.72 million

TTM EBIT

$220.52 M
AMPH TTM earnings before interest & taxes is $220.52 million

TTM EPS

$3.00
AMPH TTM earnings per share is $3.00

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$240.29 M
AMPH annual EBITDA is $240.29 million

Annual Net Income

$137.54 M
AMPH annual net profit is $137.54 million

Annual Interest Expense

$27.16 M
AMPH annual interest expense is $27.16 million

Annual Income Tax

$31.83 M
AMPH annual income tax is $31.83 million

Annual D&A

$41.78 M
AMPH annual depreciation & amortization is $41.78 million

AMPH EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+64.4%-24.3%+23.1%
3 y3 years+695.9%+66.4%+82.9%
5 y5 years+3416.7%+901.8%+239.8%

AMPH EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+115.4%-24.3%+126.5%-7.4%+148.2%
5 y5-yearat high+695.9%-24.3%>+9999.0%-7.4%+826.6%
alltimeall timeat high+1292.3%-24.3%+1133.2%-7.4%+1868.5%

Amphastar Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$68.81 M(-5.7%)
$276.85 M(-7.4%)
Jun 2024
-
$73.00 M(+3.6%)
$298.95 M(+11.0%)
Mar 2024
-
$70.45 M(+9.1%)
$269.38 M(+12.1%)
Dec 2023
$240.29 M(+64.4%)
$64.59 M(-29.0%)
$240.29 M(+6.9%)
Sep 2023
-
$90.91 M(+109.3%)
$224.82 M(+36.8%)
Jun 2023
-
$43.43 M(+5.0%)
$164.40 M(+8.6%)
Mar 2023
-
$41.36 M(-15.8%)
$151.34 M(+3.5%)
Dec 2022
$146.16 M(+31.0%)
$49.11 M(+61.1%)
$146.16 M(+11.8%)
Sep 2022
-
$30.49 M(+0.4%)
$130.71 M(-9.8%)
Jun 2022
-
$30.38 M(-16.0%)
$144.91 M(+6.8%)
Mar 2022
-
$36.18 M(+7.5%)
$135.70 M(+21.6%)
Dec 2021
$111.56 M(+269.5%)
$33.66 M(-24.7%)
$111.56 M(+43.0%)
Sep 2021
-
$44.68 M(+111.1%)
$78.01 M(+65.1%)
Jun 2021
-
$21.17 M(+75.8%)
$47.25 M(+54.8%)
Mar 2021
-
$12.04 M(>+9900.0%)
$30.53 M(+1.1%)
Dec 2020
$30.19 M(-62.9%)
$116.00 K(-99.2%)
$30.19 M(-18.3%)
Sep 2020
-
$13.92 M(+212.9%)
$36.93 M(+23.6%)
Jun 2020
-
$4.45 M(-62.0%)
$29.88 M(-67.4%)
Mar 2020
-
$11.70 M(+70.6%)
$91.64 M(+12.5%)
Dec 2019
$81.47 M(+1092.3%)
$6.86 M(-0.2%)
$81.47 M(+2.4%)
Sep 2019
-
$6.87 M(-89.6%)
$79.58 M(-0.0%)
Jun 2019
-
$66.21 M(+4230.4%)
$79.58 M(+491.9%)
Mar 2019
-
$1.53 M(-69.2%)
$13.44 M(+96.8%)
Dec 2018
$6.83 M
$4.97 M(-27.7%)
$6.83 M(+40.7%)
DateAnnualQuarterlyTTM
Sep 2018
-
$6.87 M(+9060.0%)
$4.86 M(+1627.8%)
Jun 2018
-
$75.00 K(-101.5%)
$281.00 K(-96.2%)
Mar 2018
-
-$5.08 M(-269.9%)
$7.46 M(-58.7%)
Dec 2017
$17.89 M(-41.0%)
$2.99 M(+30.3%)
$18.05 M(+28.1%)
Sep 2017
-
$2.30 M(-68.3%)
$14.10 M(-35.3%)
Jun 2017
-
$7.25 M(+31.4%)
$21.80 M(-22.8%)
Mar 2017
-
$5.52 M(-670.4%)
$28.22 M(-7.0%)
Dec 2016
$30.33 M(+682.8%)
-$967.00 K(-109.7%)
$30.33 M(-32.8%)
Sep 2016
-
$10.00 M(-26.9%)
$45.12 M(+31.0%)
Jun 2016
-
$13.67 M(+79.3%)
$34.44 M(+144.1%)
Mar 2016
-
$7.63 M(-44.8%)
$14.11 M(+264.1%)
Dec 2015
$3.88 M(-225.4%)
$13.82 M(-2129.4%)
$3.88 M(-130.9%)
Sep 2015
-
-$681.00 K(-89.8%)
-$12.54 M(-19.9%)
Jun 2015
-
-$6.66 M(+155.8%)
-$15.65 M(+129.6%)
Mar 2015
-
-$2.60 M(+0.5%)
-$6.82 M(+120.6%)
Dec 2014
-$3.09 M(-109.9%)
-$2.59 M(-31.8%)
-$3.09 M(-151.8%)
Sep 2014
-
-$3.80 M(-274.6%)
$5.96 M(-56.0%)
Jun 2014
-
$2.18 M(+93.7%)
$13.56 M(-49.5%)
Mar 2014
-
$1.12 M(-82.6%)
$26.85 M(-14.1%)
Dec 2013
$31.26 M(-18.1%)
$6.46 M(+70.1%)
$31.26 M(+26.1%)
Sep 2013
-
$3.80 M(-75.4%)
$24.80 M(+18.1%)
Jun 2013
-
$15.46 M(+179.4%)
$21.00 M(+279.4%)
Mar 2013
-
$5.54 M
$5.54 M
Dec 2012
$38.16 M(-289.3%)
-
-
Dec 2011
-$20.15 M
-
-

FAQ

  • What is Amphastar Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals annual EBITDA year-on-year change?
  • What is Amphastar Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Amphastar Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals TTM EBITDA year-on-year change?

What is Amphastar Pharmaceuticals annual EBITDA?

The current annual EBITDA of AMPH is $240.29 M

What is the all time high annual EBITDA for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high annual EBITDA is $240.29 M

What is Amphastar Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, AMPH annual EBITDA has changed by +$94.13 M (+64.40%)

What is Amphastar Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of AMPH is $68.81 M

What is the all time high quarterly EBITDA for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high quarterly EBITDA is $90.91 M

What is Amphastar Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, AMPH quarterly EBITDA has changed by -$22.10 M (-24.31%)

What is Amphastar Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of AMPH is $276.85 M

What is the all time high TTM EBITDA for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high TTM EBITDA is $298.95 M

What is Amphastar Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, AMPH TTM EBITDA has changed by +$52.03 M (+23.14%)